Your session is about to expire
← Back to Search
Cryotherapy + Acupressure + Acupuncture for Gastrointestinal Cancer
Study Summary
This trial is testing whether adding acupressure and acupuncture to oral cryotherapy helps decrease chemotherapy-induced peripheral neuropathy in patients with gastrointestinal cancer who are receiving oxaliplatin-based chemotherapy.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have GI cancer and am starting a specific chemotherapy plan for 3+ months.I can receive additional biological treatments with my chemotherapy.I have nerve damage in my hands or feet.I am set to receive a lower starting dose of oxaliplatin than the usual.Your platelet count is more than 20,000 per microliter.I am scheduled for treatment with oxaliplatin and capecitabine.I am taking duloxetine to help with nerve pain.I am 18 years old or older.I have received acupuncture in the last 3 months.You need to have a certain amount of a type of white blood cell called neutrophils.
- Group 1: Arm I (acupuncture, acupressure, cryotherapy)
- Group 2: Arm II (cryotherapy)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has the FDA sanctioned Oral Cryotherapy for use?
"The safety profile of Oral Cryotherapy has been evaluated and given a score of 2, since there is evidence to support it as safe but no data showing its efficacy yet."
To what extent is the current research recruiting participants?
"Indeed, the study is currently open for participant enrollment. This trial was first listed on June 1st 2021 and has since been updated as recently as October 13th 2022 with a goal of recruiting 56 patients from one medical centre."
Is enrollment for this trial currently open to the public?
"According to records on clinicaltrials.gov, this medical trial remains open for patient recruitment and has recently been updated as of October 13th 2022. It was initially posted on June 1st 2021."
Share this study with friends
Copy Link
Messenger